Related Experiment Video
Updated: May 10, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Mucopolysaccharidosis Type II and the G374sp Mutation
E Martínez-Quintana1, F Rodríguez-González
1Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.
Abstract:
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare, X-linked disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase, which catalyses a step in the catabolism of glycosaminoglycans resulting in accumulation of heparan and dermatan sulfate in many organs and tissues. This accumulation favors the appearance of neurologic involvement, severe airway obstruction, skeletal deformities, and cardiomyopathy, especially mitral and aortic valve regurgitation. In severe cases, obstructive airway disease and cardiac failure due to valvular dysfunction are the most common causes of death within the second decade of life. However, in mild cases, intelligence remains normal, stature is almost normal and death usually occurs due to cardiac failure in the fourth decade of life. We report the presentation, diagnosis, management, and outcome of 2 siblings with MPS II and the G374sp mutation at the nucleotide c.1246 of the gene encoding for the iduronate-2-sulfatase.
Insights
Hunter syndrome (Mucopolysaccharidosis type II) is a rare genetic disorder. This study details two siblings with MPS II, highlighting their diagnosis, management, and outcomes related to a specific genetic mutation.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is an X-linked lysosomal storage disease.
- It results from iduronate-2-sulfatase deficiency, impairing glycosaminoglycan catabolism.
- Accumulation of heparan and dermatan sulfate leads to multi-organ system damage.
Observation:
- MPS II presents with diverse clinical manifestations, including neurological issues, airway obstruction, skeletal deformities, and cardiac valve regurgitation.
- Disease severity varies, impacting lifespan and cognitive function.
- Two siblings with MPS II and a specific G374sp mutation (c.1246 nucleotide) were analyzed.
Findings:
- The study reports the clinical presentation, diagnostic process, treatment strategies, and outcomes for two affected siblings.
- Specific focus on the G374sp mutation and its impact on MPS II progression.
- Detailed case report illustrating the natural history and management of MPS II.
Implications:
- Understanding genotype-phenotype correlations in MPS II is crucial for accurate diagnosis and prognosis.
- This case highlights the importance of early identification and management of MPS II.
- Further research into the G374sp mutation may inform therapeutic approaches for Hunter syndrome.
More Related Videos
06:21Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Proteoglycans
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Lysosomal Hydrolases
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can exist in...